🔗 Share this article

The top legal official in Texas Ken Paxton is taking legal action against the manufacturers of Tylenol, asserting the companies withheld alleged dangers that the drug created to children's cognitive development.

This legal action comes thirty days after President Donald Trump publicized an unverified association between taking Tylenol - alternatively called paracetamol - while pregnant and autism in children.

Paxton is suing J&J, which previously sold the drug, the exclusive pain medication approved for expectant mothers, and the current manufacturer, which now manufacturers it.

In a declaration, he stated they "misled consumers by profiting off of pain and pushing pills without regard for the risks."

Kenvue states there is insufficient reliable data connecting acetaminophen to autism.

"These companies lied for decades, deliberately risking millions to increase profits," the attorney general, a Republican, said.

The manufacturer said in a statement that it was "seriously troubled by the dissemination of inaccurate information on the security of acetaminophen and the likely effects that could have on the well-being of women and children in America."

On its online platform, the company also mentioned it had "regularly reviewed the relevant science and there is insufficient valid information that indicates a verified association between using acetaminophen and autism."

Organizations speaking for medical professionals and healthcare providers concur.

The leading OB-GYN organization has stated paracetamol - the key substance in Tylenol - is one of the few options for pregnant women to treat pain and elevated temperature, which can create significant medical dangers if not addressed.

"In more than two decades of investigation on the use of acetaminophen in pregnancy, zero credible investigations has definitively established that the consumption of acetaminophen in any stage of gestation results in brain development issues in young ones," the organization stated.

This legal action references recent announcements from the former administration in claiming the medication is allegedly unsafe.

Last month, Trump caused concern from medical authorities when he advised pregnant women to "resist strongly" not to take Tylenol when unwell.

The FDA then issued a notice that medical professionals should contemplate reducing the usage of acetaminophen, while also stating that "a causal relationship" between the drug and autism spectrum disorder in young ones has not been established.

The Health Department head Robert F Kennedy Jr, who supervises the FDA, had promised in spring to undertake "a massive testing and research effort" that would establish the source of autism in a short period.

But experts cautioned that identifying a sole reason of autism spectrum disorder - considered by experts to be the result of a complex mix of inherited and surrounding conditions - would be difficult.

Autism is a category of permanent neurological difference and impairment that affects how people encounter and engage with the world, and is identified using physician assessments.

In his lawsuit, Paxton - a Trump ally who is seeking US Senate - asserts Kenvue and Johnson & Johnson "willfully ignored and attempted to silence the research" around paracetamol and autism.

This legal action seeks to make the corporations "destroy any marketing or advertising" that states acetaminophen is secure for pregnant women.

The court case mirrors the grievances of a collection of parents of children with autism and attention deficit hyperactivity disorder who sued the producers of acetaminophen in two years ago.

Judicial authorities threw out the legal action, stating research from the plaintiffs' authorities was inconclusive.